Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression

Area of Science:

• Hematology
• Molecular Biology
• Immunology

Background:

• Oligodendrocyte transcription factor 2 (OLIG2) is a basic helix-loop-helix transcription factor crucial for oligodendrocyte and motor neuron lineage specification.
• Siglec-8 is a key marker of eosinophil differentiation involved in inducing eosinophil apoptosis.

Purpose of the Study:

• To investigate the expression and function of OLIG2 in human eosinophils.
• To determine OLIG2's role in the transcriptional regulation of Siglec-8 in eosinophils.

Main Methods:

• Culture of CD34+ hematopoietic stem cells to differentiate into eosinophils.
• Protein and RNA expression analysis (Western blot, RT-PCR, RNA sequencing, FACS).
• Gene silencing using small interfering RNA (siRNA) and short hairpin RNA (shRNA).
• Reporter gene assays and chromatin immunoprecipitation (ChIP) to assess transcriptional regulation.

Main Results:

• OLIG2 protein is expressed in fully differentiated human eosinophils but not in other leukocytes like neutrophils or lymphocytes.
• OLIG2 expression is significantly upregulated during eosinophil differentiation.
• Knockdown of OLIG2 leads to downregulation of SIGLEC-8 mRNA and protein.
• OLIG2 directly binds to an E-box motif in the SIGLEC-8 gene intron, activating its transcription.

Conclusions:

• OLIG2 plays a critical role in the differentiation of human eosinophils.
• OLIG2 regulates the expression of Siglec-8, a key eosinophil apoptosis-inducing marker.
• This study identifies OLIG2 as a novel transcription factor involved in granulocyte function.